FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...
Chris R. Alabiad, MD: There wasn’t one single national rule change in 2025 that transformed residency training overnight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback